Nutrición Hospitalaria 00463 / http://dx.doi.org/10.20960/nh.463

Trabajo Original

Irisin is weakly associated with usual physical activity in young overweight women

Beatriz Tenorio, Teresa Jiménez, Gladys Barrera, Sandra Hirsch, Maria Pia De La Maza, Rodrigo Troncoso, María Belén Farias, Juan Manuel Rodríguez, Daniel Bunout

VOLUMEN 34, NÚM. 3, mayo-junio (2017), PAG. 688-692

Logo Descargas Número de descargas: 6227 Logo Visitas Número de visitas: 7563 Citas Citas: 0

Compártelo:

Purpose: To determine if irisin plasma levels are associated with regular physical activity, body composition and metabolic parameters in women subjected to calorie restriction.Subjects and methods: We studied 42 women aged 34 ± 13 years with a body mass index of 27.7 ± 1.8 kg/m2, who were subjected to a calorie restriction for three months. At baseline and at the end of the study, weight, waist and hip circumference, laboratory parameters, body composition by DEXA, resting and activity energy expenditure by indirect calorimetry and 72 hours actigraphy were measured. Fasting serum irisin was quantified using an ELISA kit.Results: After the intervention period, participants lost 1.5 (0.4-3.4) kg and irisin levels did not change. Irisin baseline levels were positively but weakly correlated with the level of physical activity. This association was lost at the end of the intervention. No association was found between irisin levels and body composition or insulin sensitivity or their changes after calorie restriction. No association between serum irisin levels and PGC-1αexpression in peripheral blood mononuclear cells and serum irisin was observed.Conclusions: Fasting serum irisin was weakly associated with usual physical activity and did not change after calorie restriction.

Palabras Clave: Irisin. Calorie restriction. PGC-1α.

Descargar PDF (ENGLISH)

Bibliografía

Boström, P. et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 481,463-8 (2012).

Castillo-Quan JI. From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity. Dis Model Mech. 2012;5:293-5
DOI: 10.1242/dmm.009894

Liu J. Irisin as an exercise-stimulated hormone binding crosstalk between organs. Eur Rev Med Pharmacol Sci. 2012;19:316-21.

Irving BA, Still CD, Argyropoulos G. Does IRISIN Have a BRITE Future as a Therapeutic Agent in Humans? Curr Obes Rep. 2014;3:235-41 (2014).

Vaughan RA, Gannon NP, Barberena MA, Garcia-Smith R, Bisoffi M, Mermier CM et a. Characterization of the metabolic effects of irisin on skeletal muscle in vitro. Diabetes Obes Metab. 2014;16:711-8
DOI: 10.1111/dom.12268

Choi HY, Kim S, Park JW, Lee NS, Hwang SY, Huh JY et al. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans. J Clin Endocrinol Metab. 2014;99:2778-85
DOI: 10.1210/jc.2014-1195

Chen JQ, Fang LJ, Song KX, Wang XC, Huang YY, Chai SY et al. Serum Irisin Level is Higher and Related with Insulin in Acanthosis Nigricans-related Obesity. Exp Clin Endocrinol Diabetes. 2015 Nov 20. [Epub ahead of print]

Anastasilakis AD, Polyzos SA, Saridakis ZG, Kynigopoulos G, Skouvaklidou EC, Molyvas D et al. Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition. J Clin Endocrinol Metab. 2014;99:3247-55
DOI: 10.1210/jc.2014-1367

Miyamoto-Mikami E, Sato K, Kurihara T, Hasegawa N, Fujie S, Fujita S et al. Endurance training-induced increase in circulating irisin levels is associated with reduction of abdominal visceral fat in middle-aged and older adults. PLoS One. 2015;10:e0120354

Gao S, Cheng Y, Zhao L, Chen Y, Liu Y. The relationships of irisin with bone mineral density and body composition in PCOS patients. Diabetes Metab Res Rev. 2015 Nov 21.

Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A et al. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J. 2014;281:739-49
DOI: 10.1111/febs.12619

Löffler D, Müller U, Scheuermann K, Friebe D, Gesing J, Bielitz J et al. Serum irisin levels are regulated by acute strenuous exercise. J Clin Endocrinol Metab. 2015;100:1289-99
DOI: 10.1210/jc.2014-2932

Pardo M, Crujeiras AB, Amil M, Aguera Z, Jiménez-Murcia S, Baños R et al. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol. 2014;2014:857270
DOI: 10.1155/2014/857270

Al-Daghri NM, Alokail MS, Rahman S, Amer OE, Al-Attas OS, Alfawaz H et al. Habitual physical activity is associated with circulating irisin in healthy controls but not in subjects with diabetes mellitus type 2. Eur J Clin Invest. 2015;45:775-81
DOI: 10.1111/eci.12468

Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-70
DOI: 10.2337/diacare.22.9.1462

Gajardo H, Barrera G. [Quality control of bone densitometry: precision, reproducibility, and clinical application]. Rev Med Chil. 1998;126:56-62.

Crouter SE, Churilla JR, Bassett DR, Jr. Accuracy of the Actiheart for the assessment of energy expenditure in adults. Eur J Clin Nutr. 2008;62:704-11
DOI: 10.1038/sj.ejcn.1602766

Spierer DK, Hagins M, Rundle A, Pappas E. A comparison of energy expenditure estimates from the Actiheart and Actical physical activity monitors during low intensity activities, walking, and jogging. Eur J Appl Physiol. 2011;111:659-67.
DOI: 10.1007/s00421-010-1672-7

Novelle MG, Contreras C, Romero-Picó A, López M, Diéguez C. Irisin, two years later. Int J Endocrinol. 2013;2013:746281
DOI: 10.1155/2013/746281

Albrecht E, Norheim F, Thiede B, Holen T, Ohashi T, Schering L et al. Irisin - a myth rather than an exercise-inducible myokine. Sci Rep. 2015 Mar 9;5:8889.

Polyzos SA, Mantzoros CS. An update on the validity of irisin assays and the link between irisin and hepatic metabolism. Metabolism. 2015;64:937-42
DOI: 10.1016/j.metabol.2015.06.005

Jedrychowski MP, Wrann CD, Paulo JA, Gerber KK, Szpyt J, Robinson MM et al. Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry. Cell Metab. 2015;22:734-40
DOI: 10.1016/j.cmet.2015.08.001

Kim H, Lee HJ, So B, Son JS, Yoon D, Song W. Effect of aerobic training and resistance training on circulating irisin level and their association with change of body composition in overweight/obese adults: a pilot study. Physiol Res. 2015 Oct 8. [Epub ahead of print]

Crujeiras AB, Pardo M, Arturo RR, Navas-Carretero S, Zulet MA, Martínez JA et al. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women. Am J Hum Biol. 2014;26:198-207
DOI: 10.1002/ajhb.22493

Ruchala M, Zybek A, Szczepanek-Parulska E. Serum irisin levels and thyroid function--newly discovered association. Peptides. 2014;60:51-5
DOI: 10.1016/j.peptides.2014.07.021

Assyov Y, Gateva A, Tsakova A, Kamenov Z. Irisin in the Glucose Continuum. Exp Clin Endocrinol Diabetes. 2015 Oct 19. [Epub ahead of print]

Duran ID, Gülçelik NE, Ünal M, Topçuoğlu C, Sezer S, Tuna MM et al. Irisin levels in the progression of diabetes in sedentary women. Clin Biochem. 2015;48:1268-72
DOI: 10.1016/j.clinbiochem.2015.07.098

Yang Z, Chen X, Chen Y, Zhao Q. PGC-1 mediates the regulation of metformin in muscle irisin expression and function. Am J Transl Res. 2015;7:1850-9

Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61:1725-38
DOI: 10.1016/j.metabol.2012.09.002

Pekkala S, Wiklund PK, Hulmi JJ, Ahtiainen JP, Horttanainen M, Pöllänen E et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol. 2013;591:5393-400